Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment
Mahsa Mortaja, Marcus M Cheng, Alina Ali, Jacqueline Lesperance, Dina V Hingorani, Mike M Allevato, Kanika Dhawan, Maria F Camargo, Rana R McKay, Stephen R Adams, J Silvio Gutkind, Sunil J Advani · 2024
Read Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment by Mahsa Mortaja, Marcus M Cheng, Alina Ali, Jacqueline Lesperance, Dina V Hingorani, Mike M Allevato, Kanika Dhawan, Maria F Camargo, Rana R McKay, Stephen R Adams, J Silvio Gutkind, Sunil J Advani (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11643828.txt.
Description
Mahsa Mortaja and co-authors study how a potent cancer drug reshapes the immune scene inside tumors over time, in a research paper from 2024. The drug, a cell-killing payload used in targeted medicines, is ferried by peptides that wake up only inside tumors. Tumors raise levels of cutting enzymes, and the peptides use those enzymes as the key.
In mouse cancer models, the team tracked how the payload changed immune cell behavior across days. The peptide carriers proved flexible for delivering the drug to tumors. The time pattern matters: the same drug can stir or settle immune activity depending on when one looks. The work guides pairing such payloads with immune therapy.
Catalog record
| CREATOR | Mahsa Mortaja, Marcus M Cheng, Alina Ali, Jacqueline Lesperance, Dina V Hingorani, Mike M Allevato, Kanika Dhawan, Maria F Camargo, Rana R McKay, Stephen R Adams, J Silvio Gutkind, Sunil J Advani |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |